Study of Ravulizumab in Pediatric Participants With Primary IgAN

Clinical trial NCT07024563 · RECRUITING

Trial details

NCT number: NCT07024563
Sponsor: Alexion Pharmaceuticals, Inc.
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

IgAN IgAVN Immunoglobulin A Nephropathy Immunoglobulin A Vasculitis Associated Nephritis Henoch-schonlein Purpura Nephritis IgA Vasculitis

Start date: 2025-06-14
Primary completion: 2028-11-29
Enrollment: 36

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.